Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Zogenix Inc (NASDAQ:ZGNX)

9.11
Delayed Data
As of Feb 10
 +0.63 / +7.43%
Today’s Change
7.90
Today|||52-Week Range
21.65
-38.20%
Year-to-Date
No recent news for Zogenix Inc.

Today’s Trading

Previous close8.48
Today’s open8.54
Day’s range8.49 - 9.25
Volume433,913
Average volume (3 months)375,588
Market cap$225.6M
Dividend yield--
Data as of 02/10/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)+121.41%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+22.78%
P/E ratioNM
Price/Sales4.90
Price/Book3.16

Competitors

 Today’s
change
Today’s
% change
LBIOLion Biotechnologies...-0.13-2.68%
HSKAHeska Corp-0.94-2.70%
AGTCApplied Genetic Tech...+0.26+2.16%
PRTKParatek Pharmaceutic...+0.37+2.90%
Data as of 02/10/2016

Financials

Next reporting dateMarch 3, 2016
EPS forecast (this quarter)-$0.69
Annual revenue (last year)$40.5M
Annual profit (last year)$8.6M
Net profit margin21.19%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Stephen J. Farr
CFO, Secretary, Treasurer &
Executive VP
Ann D. Rhoads
Corporate headquarters
San Diego, California

Forecasts

Partner Offers